BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/19/2017 8:56:36 PM | Browse: 156 | Download: 609
Publication Name World Journal of Gastroenterology
Manuscript ID 35229
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
Manuscript Source Unsolicited Manuscript
All Author List Jia-Zhou Ye, Jun-Ze Chen, Zi-Hui Li, Tao Bai, Jie Chen, Shao-Liang Zhu, Le-Qun Li and Fei-Xiang Wu
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of Guangxi 2012GXNSFAA053162
Key project of Guangxi Health and Family Planning Commission, China S201513
Key Project of Guangxi Science and Technology Department, China Gui Ke AB16380242
Corresponding Author Fei-Xiang Wu, MD, Professor, Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, He Di Road No. 71, Nanning 530021, Guangxi Zhuang Autonomous Region, China. wufeixiang@gxmu.edu.cn
Key Words Hepatocellular carcinoma; Microvascular invasion; Postoperative adjuvant transcatheter arterial chemoembolization; Recurrence-free survival; Overall survival
Core Tip Microvascular invasion (MVI) is an independent risk factor attributed to frequent tumor recurrence in Barcelona Clinic Liver Cancer (BCLC) early- and intermediate-stage hepatocellular carcinoma (HCC) patients. Postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) has been confirmed to be effective in suppressing early recurrence and delaying the progression of recurrent tumors, thereby improving the overall survival (OS) in HCC patients with macrovascular invasion. However, whether PA-TACE could provide the survival benefit to HCC patients with MVI remains unclear. The present study showed that PA-TACE is an effective method that can safely suppress the recurrence and improve the survival of BCLC early- and intermediate-stage HCC patients with MVI. However, it failed to provide obvious OS or recurrence-free survival benefits to patients without MVI.
Citation Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. World J Gastroenterol 2017; 23(41): 7415-7424
Received
2017-07-26 01:08
Peer-Review Started
2017-07-26 12:51
To Make the First Decision
2017-08-10 00:28
Return for Revision
2017-08-14 13:32
Revised
2017-09-09 05:26
Second Decision
2017-09-15 00:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-09-19 20:56
Articles in Press
2017-09-19 20:56
Publication Fee Transferred
2017-10-02 14:49
Edit the Manuscript by Language Editor
2017-10-16 13:26
Typeset the Manuscript
2017-10-31 03:50
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com